Technological advances have had a major effect on the management of type 1 diabetes. In
addition to blood glucose meters, devices used by people with type 1 diabetes include …

Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Objective: To provide a snapshot of the profile of adults and youth with type 1 diabetes (T1D)
in the United States and assessment of longitudinal changes in T1D management and …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

Introduction: This trial assessed safety and effectiveness of an advanced hybrid closed-loop
(AHCL) system with automated basal (Auto Basal) and automated bolus correction (Auto …

OBJECTIVE Advances in diabetes technology have transformed the treatment paradigm for
type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study …

Objective The objective is to formulate clinical practice guidelines for the treatment of
diabetes in older adults. Conclusions Diabetes, particularly type 2, is becoming more …

This is the author's manuscript of the article published in final edited form as: DiMeglio, LA,
Acerini, CL, Codner, E., Craig, ME, Hofer, SE, Pillay, K., & Maahs, DM (2018). ISPAD Clinical …

Background Type 1 diabetes is a chronic autoimmune disease that leads to destruction of
insulin-producing beta cells and dependence on exogenous insulin for survival. Some …

BACKGROUND A previous phase I study showed that the infusion of autologous Tregs
expanded ex vivo into patients with recent-onset type 1 diabetes (T1D) had an excellent …